Current Issue : January - March Volume : 2021 Issue Number : 1 Articles : 5 Articles
Background: Interstitial Lung Disease (ILD) is a group of respiratory conditions affecting the lung interstitium often\nassociated with progressive respiratory failure. There is increasing recognition of the need for improved epidemiological data\nto help determine best practice and improve standardisation of care. The Australasian ILD Registry (AILDR) is a bi-national\nregistry of patients with all ILD subtypes designed to establish a clinically meaningful database reflecting real world practice in\nAustralasia with an objective to improve diagnostic and treatment pathways through research and collaboration.\nMethods: AILDR is a prospective observational registry recruiting patients attending ILD clinics at centres around Australia and\nNew Zealand. Core and non-core data are stored on a secure server. The pilot phase was launched in 2016 consisting of four\nsites in Australia. Currently in its second phase a further 16 sites have been recruited, including three in New Zealand.........................
Background: Nontuberculous mycobacterial (NTM) lung disease is one of a growing number of chronic health\nproblems that is difficult to cure in aging societies. While it is important to be vigilant about associated\ncomorbidities in order to provide better patient care, data on the prevalence of comorbidities stratified by country\nor region are scarce. We aimed to elucidate the comorbidities associated with NTM disease based on Japanese\nhealth insurance claims data.\nMethods: Cross-sectional analyses were performed using the claims data for 2014 provided by the Japan Medical\nData Center Co., Ltd. Patients................................
Background: Postoperative pulmonary complications (PPCs) and hypoxaemia are associated with morbidity and\nmortality. We aimed to evaluate the feasibility and efficacy of lung ultrasound (LUS) to diagnose PPCs in patients\nsuffering from hypoxaemia after general anaesthesia and compare the results to those of thoracic computed\ntomography (CT).\nMethods: Adult patients who received general anaesthesia and suffered from hypoxaemia in the postanaesthesia\ncare unit (PACU) were analysed..........................
Background: Hermansky-Pudlak syndrome (HPS) is an extremely rare disease with pulmonary fibrosis (PF),\noculocutaneous albinism, induced platelet dysfunction, and granulomatous colitis. Although patients with HPSassociated\nPF (HPS-PF) often receive treatment with anti-fibrotic agents, including pirfenidone, many HPS-PF cases\nare progressive. The development of pneumothorax is known to be rare in HPS-PF. Pneumothorax development is\ngenerally important for prognosis in patients with interstitial pneumonia. However, there are few reports regarding\nthe development of pneumothorax in patients with HPS-PF............................
Background: The optimal duration of antibiotic treatment for community-acquired pneumonia (CAP) is not well\nestablished. The aim of this study was to assess the impact of reducing the duration of antibiotic treatment on\nlong-term prognosis in patients hospitalized with CAP.\nMethods: This was a multicenter study assessing complications developed during 1 year of patients previously\nhospitalized with CAP who had been included in a randomized clinical trial concerning the duration of antibiotic\ntreatment. Mortality at 90 days, at 180 days and at 1 year was analyzed, as well as new admissions and\ncardiovascular complications. A subanalysis was carried out in one of the hospitals by measuring C-reactive protein\n(CRP), procalcitonin (PCT) and proadrenomedullin (proADM) at admission, at day 5 and at day 30.........................
Loading....